Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has ...
The central pattern generator (CPG) networks that generate relatively simple motor outputs are ideal experimental models for circuit analysis. Locomotor CPGs in the ventral spinal cord function ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results